Loading…

Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors

This study explores whether objective, quantitative radiomic biomarkers derived from magnetic resonance (MR), positron emission tomography (PET), and computed tomography (CT) may be useful in reliably distinguishing malignant peripheral nerve sheath tumors (MPNST) from benign plexiform neurofibromas...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroradiology 2019-05, Vol.46 (3), p.179-185
Main Authors: Uthoff, J., De Stefano, F.A., Panzer, K., Darbro, B.W., Sato, T.S., Khanna, R., Quelle, D.E., Meyerholz, D.K., Weimer, J., Sieren, J.C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53
cites cdi_FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53
container_end_page 185
container_issue 3
container_start_page 179
container_title Journal of neuroradiology
container_volume 46
creator Uthoff, J.
De Stefano, F.A.
Panzer, K.
Darbro, B.W.
Sato, T.S.
Khanna, R.
Quelle, D.E.
Meyerholz, D.K.
Weimer, J.
Sieren, J.C.
description This study explores whether objective, quantitative radiomic biomarkers derived from magnetic resonance (MR), positron emission tomography (PET), and computed tomography (CT) may be useful in reliably distinguishing malignant peripheral nerve sheath tumors (MPNST) from benign plexiform neurofibromas (PN). A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imaging of the PN including MR and PET-CT. The corrected MR datasets were registered to the corresponding PET-CT via landmark-based registration. PET standard-uptake value (SUV) thresholds were used to guide segmentation of volumes of interest: MPNST-associated PET-hot regions (SUV≥3.5) and PN-associated PET-elevated regions (2.0
doi_str_mv 10.1016/j.neurad.2018.05.006
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6310110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0150986117305199</els_id><sourcerecordid>2062837186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53</originalsourceid><addsrcrecordid>eNp9UctOwzAQ9AFEy-MPEMqRS4IfsZNckBDiJSEhIThbrr0GlyQudlLB3-OqpcCF02q1M7s7MwgdE1wQTMTZvOhhDMoUFJO6wLzAWOygKSYc500tyATtxzjHmBJS0j00oU3D67qspkg_KuN853Q2S0WFNwgxc731oVODW0LmbaZVryH4MWZDUH3czHyfcNnqrrduFhJ58NHFnGSLFj7cCpUNY-dDPES7VrURjjb1AD1fXz1d3ub3Dzd3lxf3uS4FG3LGeS0MNKWmuqqYtaVJg5pTownmtmHamEpw1mjKuWVAGsMU5xpDmXrL2QE6X-9djLMOjIY-_dvKRXBJ2Kf0ysm_k969yhe_lIIlFwlOC043C4J_HyEOsnNRQ9uqHpJ8SbGgNatILRK0XEN18DEGsNszBMtVJnIu15nIVSYSc5kySbST3y9uSd-B_GiAZNTSQZBRO0j-GxdAD9J49_-FL_eSpVs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2062837186</pqid></control><display><type>article</type><title>Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors</title><source>ScienceDirect Freedom Collection</source><creator>Uthoff, J. ; De Stefano, F.A. ; Panzer, K. ; Darbro, B.W. ; Sato, T.S. ; Khanna, R. ; Quelle, D.E. ; Meyerholz, D.K. ; Weimer, J. ; Sieren, J.C.</creator><creatorcontrib>Uthoff, J. ; De Stefano, F.A. ; Panzer, K. ; Darbro, B.W. ; Sato, T.S. ; Khanna, R. ; Quelle, D.E. ; Meyerholz, D.K. ; Weimer, J. ; Sieren, J.C.</creatorcontrib><description>This study explores whether objective, quantitative radiomic biomarkers derived from magnetic resonance (MR), positron emission tomography (PET), and computed tomography (CT) may be useful in reliably distinguishing malignant peripheral nerve sheath tumors (MPNST) from benign plexiform neurofibromas (PN). A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imaging of the PN including MR and PET-CT. The corrected MR datasets were registered to the corresponding PET-CT via landmark-based registration. PET standard-uptake value (SUV) thresholds were used to guide segmentation of volumes of interest: MPNST-associated PET-hot regions (SUV≥3.5) and PN-associated PET-elevated regions (2.0&lt;SUV&lt;3.5). Quantitative imaging features were extracted from the MR, PET, and CT data and compared for statistical differences. Intensity histogram features included (mean, media, maximum, variance, full width at half maximum, entropy, kurtosis, and skewness), while image texture was quantified using Law's texture energy measures, grey-level co-occurrence matrices, and neighborhood grey-tone difference matrices. For each of the 20 NF1 subjects, a total of 320 features were extracted from the image data. Feature reduction and statistical testing identified 9 independent radiomic biomarkers from the MR data (4 intensity and 5 texture) and 4 PET (2 intensity and 2 texture) were different between the PET-hot versus PET-elevated volumes of interest. Our data suggests imaging features can be used to distinguish malignancy in NF1-realted tumors, which could improve MPNST risk assessment and positively impact clinical management of NF1 patients.</description><identifier>ISSN: 0150-9861</identifier><identifier>DOI: 10.1016/j.neurad.2018.05.006</identifier><identifier>PMID: 29958847</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Biomarkers, Tumor - analysis ; Cell Transformation, Neoplastic ; Diagnosis, Differential ; Female ; Humans ; Image Interpretation, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Malignant peripheral nerve sheath tumor ; Nerve Sheath Neoplasms - diagnostic imaging ; Nerve Sheath Neoplasms - pathology ; Neurofibromatosis 1 - diagnostic imaging ; Neurofibromatosis 1 - pathology ; Plexiform neurofibroma ; Positron emission tomography ; Positron Emission Tomography Computed Tomography ; Quantitative feature extraction ; Reproducibility of Results ; Retrospective Studies ; Young Adult</subject><ispartof>Journal of neuroradiology, 2019-05, Vol.46 (3), p.179-185</ispartof><rights>2018 Elsevier Masson SAS</rights><rights>Copyright © 2018 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53</citedby><cites>FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29958847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uthoff, J.</creatorcontrib><creatorcontrib>De Stefano, F.A.</creatorcontrib><creatorcontrib>Panzer, K.</creatorcontrib><creatorcontrib>Darbro, B.W.</creatorcontrib><creatorcontrib>Sato, T.S.</creatorcontrib><creatorcontrib>Khanna, R.</creatorcontrib><creatorcontrib>Quelle, D.E.</creatorcontrib><creatorcontrib>Meyerholz, D.K.</creatorcontrib><creatorcontrib>Weimer, J.</creatorcontrib><creatorcontrib>Sieren, J.C.</creatorcontrib><title>Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors</title><title>Journal of neuroradiology</title><addtitle>J Neuroradiol</addtitle><description>This study explores whether objective, quantitative radiomic biomarkers derived from magnetic resonance (MR), positron emission tomography (PET), and computed tomography (CT) may be useful in reliably distinguishing malignant peripheral nerve sheath tumors (MPNST) from benign plexiform neurofibromas (PN). A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imaging of the PN including MR and PET-CT. The corrected MR datasets were registered to the corresponding PET-CT via landmark-based registration. PET standard-uptake value (SUV) thresholds were used to guide segmentation of volumes of interest: MPNST-associated PET-hot regions (SUV≥3.5) and PN-associated PET-elevated regions (2.0&lt;SUV&lt;3.5). Quantitative imaging features were extracted from the MR, PET, and CT data and compared for statistical differences. Intensity histogram features included (mean, media, maximum, variance, full width at half maximum, entropy, kurtosis, and skewness), while image texture was quantified using Law's texture energy measures, grey-level co-occurrence matrices, and neighborhood grey-tone difference matrices. For each of the 20 NF1 subjects, a total of 320 features were extracted from the image data. Feature reduction and statistical testing identified 9 independent radiomic biomarkers from the MR data (4 intensity and 5 texture) and 4 PET (2 intensity and 2 texture) were different between the PET-hot versus PET-elevated volumes of interest. Our data suggests imaging features can be used to distinguish malignancy in NF1-realted tumors, which could improve MPNST risk assessment and positively impact clinical management of NF1 patients.</description><subject>Biomarkers, Tumor - analysis</subject><subject>Cell Transformation, Neoplastic</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Malignant peripheral nerve sheath tumor</subject><subject>Nerve Sheath Neoplasms - diagnostic imaging</subject><subject>Nerve Sheath Neoplasms - pathology</subject><subject>Neurofibromatosis 1 - diagnostic imaging</subject><subject>Neurofibromatosis 1 - pathology</subject><subject>Plexiform neurofibroma</subject><subject>Positron emission tomography</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Quantitative feature extraction</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Young Adult</subject><issn>0150-9861</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9UctOwzAQ9AFEy-MPEMqRS4IfsZNckBDiJSEhIThbrr0GlyQudlLB3-OqpcCF02q1M7s7MwgdE1wQTMTZvOhhDMoUFJO6wLzAWOygKSYc500tyATtxzjHmBJS0j00oU3D67qspkg_KuN853Q2S0WFNwgxc731oVODW0LmbaZVryH4MWZDUH3czHyfcNnqrrduFhJ58NHFnGSLFj7cCpUNY-dDPES7VrURjjb1AD1fXz1d3ub3Dzd3lxf3uS4FG3LGeS0MNKWmuqqYtaVJg5pTownmtmHamEpw1mjKuWVAGsMU5xpDmXrL2QE6X-9djLMOjIY-_dvKRXBJ2Kf0ysm_k969yhe_lIIlFwlOC043C4J_HyEOsnNRQ9uqHpJ8SbGgNatILRK0XEN18DEGsNszBMtVJnIu15nIVSYSc5kySbST3y9uSd-B_GiAZNTSQZBRO0j-GxdAD9J49_-FL_eSpVs</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Uthoff, J.</creator><creator>De Stefano, F.A.</creator><creator>Panzer, K.</creator><creator>Darbro, B.W.</creator><creator>Sato, T.S.</creator><creator>Khanna, R.</creator><creator>Quelle, D.E.</creator><creator>Meyerholz, D.K.</creator><creator>Weimer, J.</creator><creator>Sieren, J.C.</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors</title><author>Uthoff, J. ; De Stefano, F.A. ; Panzer, K. ; Darbro, B.W. ; Sato, T.S. ; Khanna, R. ; Quelle, D.E. ; Meyerholz, D.K. ; Weimer, J. ; Sieren, J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomarkers, Tumor - analysis</topic><topic>Cell Transformation, Neoplastic</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Malignant peripheral nerve sheath tumor</topic><topic>Nerve Sheath Neoplasms - diagnostic imaging</topic><topic>Nerve Sheath Neoplasms - pathology</topic><topic>Neurofibromatosis 1 - diagnostic imaging</topic><topic>Neurofibromatosis 1 - pathology</topic><topic>Plexiform neurofibroma</topic><topic>Positron emission tomography</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Quantitative feature extraction</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uthoff, J.</creatorcontrib><creatorcontrib>De Stefano, F.A.</creatorcontrib><creatorcontrib>Panzer, K.</creatorcontrib><creatorcontrib>Darbro, B.W.</creatorcontrib><creatorcontrib>Sato, T.S.</creatorcontrib><creatorcontrib>Khanna, R.</creatorcontrib><creatorcontrib>Quelle, D.E.</creatorcontrib><creatorcontrib>Meyerholz, D.K.</creatorcontrib><creatorcontrib>Weimer, J.</creatorcontrib><creatorcontrib>Sieren, J.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuroradiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uthoff, J.</au><au>De Stefano, F.A.</au><au>Panzer, K.</au><au>Darbro, B.W.</au><au>Sato, T.S.</au><au>Khanna, R.</au><au>Quelle, D.E.</au><au>Meyerholz, D.K.</au><au>Weimer, J.</au><au>Sieren, J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors</atitle><jtitle>Journal of neuroradiology</jtitle><addtitle>J Neuroradiol</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>46</volume><issue>3</issue><spage>179</spage><epage>185</epage><pages>179-185</pages><issn>0150-9861</issn><abstract>This study explores whether objective, quantitative radiomic biomarkers derived from magnetic resonance (MR), positron emission tomography (PET), and computed tomography (CT) may be useful in reliably distinguishing malignant peripheral nerve sheath tumors (MPNST) from benign plexiform neurofibromas (PN). A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imaging of the PN including MR and PET-CT. The corrected MR datasets were registered to the corresponding PET-CT via landmark-based registration. PET standard-uptake value (SUV) thresholds were used to guide segmentation of volumes of interest: MPNST-associated PET-hot regions (SUV≥3.5) and PN-associated PET-elevated regions (2.0&lt;SUV&lt;3.5). Quantitative imaging features were extracted from the MR, PET, and CT data and compared for statistical differences. Intensity histogram features included (mean, media, maximum, variance, full width at half maximum, entropy, kurtosis, and skewness), while image texture was quantified using Law's texture energy measures, grey-level co-occurrence matrices, and neighborhood grey-tone difference matrices. For each of the 20 NF1 subjects, a total of 320 features were extracted from the image data. Feature reduction and statistical testing identified 9 independent radiomic biomarkers from the MR data (4 intensity and 5 texture) and 4 PET (2 intensity and 2 texture) were different between the PET-hot versus PET-elevated volumes of interest. Our data suggests imaging features can be used to distinguish malignancy in NF1-realted tumors, which could improve MPNST risk assessment and positively impact clinical management of NF1 patients.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29958847</pmid><doi>10.1016/j.neurad.2018.05.006</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0150-9861
ispartof Journal of neuroradiology, 2019-05, Vol.46 (3), p.179-185
issn 0150-9861
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6310110
source ScienceDirect Freedom Collection
subjects Biomarkers, Tumor - analysis
Cell Transformation, Neoplastic
Diagnosis, Differential
Female
Humans
Image Interpretation, Computer-Assisted
Magnetic Resonance Imaging
Male
Malignant peripheral nerve sheath tumor
Nerve Sheath Neoplasms - diagnostic imaging
Nerve Sheath Neoplasms - pathology
Neurofibromatosis 1 - diagnostic imaging
Neurofibromatosis 1 - pathology
Plexiform neurofibroma
Positron emission tomography
Positron Emission Tomography Computed Tomography
Quantitative feature extraction
Reproducibility of Results
Retrospective Studies
Young Adult
title Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A23%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiomic%20biomarkers%20informative%20of%20cancerous%20transformation%20in%20neurofibromatosis-1%20plexiform%20tumors&rft.jtitle=Journal%20of%20neuroradiology&rft.au=Uthoff,%20J.&rft.date=2019-05-01&rft.volume=46&rft.issue=3&rft.spage=179&rft.epage=185&rft.pages=179-185&rft.issn=0150-9861&rft_id=info:doi/10.1016/j.neurad.2018.05.006&rft_dat=%3Cproquest_pubme%3E2062837186%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c463t-35586de94c2c773ff4dc46852dc105f93cdd76539c255f3e19d3a55c0e455ff53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2062837186&rft_id=info:pmid/29958847&rfr_iscdi=true